What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Biochemistry
Yoshio Takei mostly deals with Internal medicine, Endocrinology, Atrial natriuretic peptide, Receptor and Natriuretic peptide.
His Internal medicine study frequently involves adjacent topics like Osmoregulation.
His Endocrinology study incorporates themes from Japanese eel and Gill.
Yoshio Takei combines subjects such as Peptide, Peptide sequence, Venous return curve and Peptide hormone with his study of Atrial natriuretic peptide.
His Receptor research incorporates themes from Signal transduction and Cell biology.
The concepts of his Natriuretic peptide study are interwoven with issues in Aortic pressure, Circulatory system, Biochemistry and Cardiac output.
His most cited work include:
- Molecular biology of major components of chloride cells. (247 citations)
- Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator (219 citations)
- Four functionally distinct C-type natriuretic peptides found in fish reveal evolutionary history of the natriuretic peptide system. (121 citations)
What are the main themes of his work throughout his whole career to date?
Yoshio Takei mainly focuses on Internal medicine, Endocrinology, Natriuretic peptide, Receptor and Renin–angiotensin system.
Internal medicine is closely attributed to Osmoregulation in his research.
The study incorporates disciplines such as Adrenomedullin, Peptide, Japanese eel and Cell biology in addition to Endocrinology.
Yoshio Takei interconnects Brain natriuretic peptide, Molecular biology and Peptide sequence in the investigation of issues within Natriuretic peptide.
His Receptor study integrates concerns from other disciplines, such as Extracellular, In vitro and Binding site.
His work deals with themes such as Ventricle and Peptide hormone, which intersect with Atrial natriuretic peptide.
He most often published in these fields:
- Internal medicine (61.43%)
- Endocrinology (61.43%)
- Natriuretic peptide (19.80%)
What were the highlights of his more recent work (between 2010-2021)?
- Endocrinology (61.43%)
- Internal medicine (61.43%)
- Cell biology (10.58%)
In recent papers he was focusing on the following fields of study:
Yoshio Takei mainly investigates Endocrinology, Internal medicine, Cell biology, Hormone and Osmoregulation.
Yoshio Takei has researched Endocrinology in several fields, including Receptor and Japanese eel.
He has included themes like Lamprey and Gene expression in his Internal medicine study.
His Cell biology research includes themes of Osmotic shock and Guanylin.
The various areas that Yoshio Takei examines in his Hormone study include Body fluid, Molecular evolution and Heart failure.
The Osmoregulation study combines topics in areas such as Osmotic concentration, Beta and Plasma osmolality.
Between 2010 and 2021, his most popular works were:
- Diverse mechanisms for body fluid regulation in teleost fishes (81 citations)
- Shared and separate functions of the RAMP-based adrenomedullin receptors (42 citations)
- B-type natriuretic peptide (BNP), not ANP, is the principal cardiac natriuretic peptide in vertebrates as revealed by comparative studies. (40 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Biochemistry
His primary areas of investigation include Internal medicine, Endocrinology, Cell biology, Osmoregulation and Angiotensin II.
His Internal medicine study frequently draws connections between adjacent fields such as Japanese eel.
Particularly relevant to Appetite is his body of work in Endocrinology.
His studies deal with areas such as Osmotic shock, Gene expression and Euryhaline as well as Cell biology.
His Osmoregulation research integrates issues from Uroguanylin and Hormone.
In Natriuretic peptide, Yoshio Takei works on issues like Ion secretion, which are connected to Atrial natriuretic peptide.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
